Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 19, 2024Inorganic ChemistryOpen Access

Exploiting Co(III)-Cyclopentadienyl Complexes To Develop Anticancer Agents

View Full Paper
Ask AI
Bookmark
Share

Authors

JMJoão Franco MachadoSCSandra CordeiroJDJoana N. Duarte

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Machado et al. (2024) studied this question.

synapsesocial.com/papers/68e734fcb6db6435876ae50ehttps://doi.org/10.1021/acs.inorgchem.3c03696
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Diverse Cobalt(II) and Iron(II/III) Coordination Complexes/Polymers Based on 4′-Pyridyl: 2,2′;6′,2″-Terpyridine: Synthesis, Structures, Catalytic and Anticancer Activities2024 · 3 citations
  2. 2Structural characterization and anticancer studies of copper(II) and cobalt(III) complexes containing N,O-donor heterocyclic chelators2024
  3. 3Cobalt(III)–Macrocyclic Scaffolds with Anti-Cancer Stem Cell Activity2024 · 1 citations
  4. 4Anti-Cancer Stem Cell Cobalt(III)-Polypyridyl Complexes Containing Salicylic Acid2024
  5. 5Synthesis, anticancer activity, and molecular docking of half-sandwich iron(II) cyclopentadienyl complexes with maleimide and phosphine or phosphite ligands2024 · 11 citations